Aspire Biopharma Inks SPAC Deal At $316M Valuation
By Jade Martinez-Pogue · September 3, 2024, 5:25 PM EDT
Aspire Biopharma Inc., advised by Sichenzia Ross Ference Carmel LLP, on Tuesday announced that it will go public through a merger with special purpose acquisition company PowerUp Acquisition Corp., led by...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login